Almac Sciences has completed the first stage of its GMP API facility expansion at its headquarters site in Craigavon, Northern Ireland. This has seen two 1,000 L glass-lined reactors added with associated filtration and drying equipment allowing the manufacture of 50-100 kg batch API output. It complements the R&D technology centre opened in 2021 for the biocatalysis, flow chemistry and peptides businesses.

Quotient Sciences held an official ribbon-cutting event to celebrate the opening of its new, £6 million drug substance manufacturing facility in Alnwick, UK, on 9 December. Among those present were Sharon Todd, CEO of the Society of Chemical Industry, and Quotient’s SVP and head of candidate development, Paul Ryan.